Intellectual Property India Publishes Patent Application for 'Glp-1/Gip Dual Agonist, And Preparation Method Therefor And Use Thereof' Filed by Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd.

MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202517011977 A) filed by Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd., Zhejiang, China, on Feb. 12, for 'glp-1/gip dual agonist, and preparation method therefor and use thereof.'

Inventor(s) include Zhang, Nan; Jiang, Chunhua; Liu, Dongzhou; Teng, Li; and Shen, Jiale.

The application for the patent was published on March 7, under issue no. 10/2025.

According to the abstract released by the Intellectual Property India: "A long-acting GLP-1/GIP dual agonist compound, wherein the compound has dual agonistic effects on a glucagon-like peptide-1 (GLP-1) receptor and a human glucose-dependent insulinotropic polypeptide (GIP) receptor. The present inve...